University of California, Davis

A Gene Editor That's a Better Fit for Plants

Gene editing has enormous potential to help feed the world’s growing population, but it’s currently difficult, time-consuming ...

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Science Daily

CRISPR/Cas9 modifies euglena to create potential biofuel source

Through genome editing using CRISPR/Cas9, researchers stably create euglena mutants that can produce wax esters with improved cold flow, making the esters suitable as feedstock for biofuels. News ...

Genome Editing Market to Cross USD 44.43 Billion by 2035, Driven by Advances in CRISPR and Therapeutic Advancements – SNS Insider

Growing Adoption of Gene Therapy Platforms, Expanding Agricultural Biotechnology Applications, and Accelerating Clinical Trial Activity Drive Robust Market Expansion.Austin, United States, Feb. 27, ...
MedPage Today

Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathy

CHICAGO – A CRISPR-Cas9-based investigational therapy was linked with a drop in serum transthyretin (TTR) levels in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according to ...
MarketBeat on MSN

CRISPR Therapeutics gains after earnings as pipeline hope grows

CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings ...